ASX:MYX

Mayne Pharma Group Limited · ASX · Healthcare · AUD · FY for 2026

Figures on this page computed 2026-11-08 13:00 UTC

Last close

n/aAUD

Market data

  • 9.9xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    AUD
    • computed
    • Computed from the filing for 2026
  • -8.5%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    AUD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 6.4%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    AUD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 3.3%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    AUD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • 0.11Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    AUD
    • Computed from the filing for 2026
    • Computed from the filing for 2026
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    AUD
    • computed

Follow one dollar

lens 1 of 9
After what it costs to make
50.1%
After running the business
-8.9%
After interest and tax
6.4%
After what it must reinvest
3.3%
Kept after the dividend
n/a
after what it costs to make, 50.1% of sales; after running the business, -8.9% of sales; after interest and tax, 6.4% of sales; after what it must reinvest, 3.3% of sales

The five stops

4 of 5 read
  • After what it costs to make192,206,00050.1%
  • After running the business-34,284,000-8.9%
  • After interest and tax24,473,0006.4%
  • After what it must reinvest12,674,0003.3%
  • Kept after the dividendn/an/a

The last stop is empty on purpose. This filing does not tag a common dividend, so what is kept after it cannot be worked out. That is not the same fact as a company that paid no dividend, and we will not print a zero for it.

What is left after the dividend is not held for this company.

What is left after the dividend is not held for this company.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

  • Sales383,676,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    AUD
  • After what it costs to make192,206,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    AUD
  • After running the business-34,284,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    AUD
  • After interest and tax24,473,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    AUD
  • After what it must reinvest12,674,000
    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    AUD
  • Kept after the dividendn/a

    Not held.

    Source
    computed
    Statement
    income
    Fiscal year
    2026
    Reported in
    AUD

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.